Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test a text-delivered counseling program to stop or reduce cannabis use among young adults (ages 18 to 25).


Clinical Trial Description

After being informed about the study and potential risks, participants will complete online screening assessments. Those who are determined to be eligible via online screening will complete a urine drug screen to confirm eligibility. Once eligibility is confirmed, participants will be randomized either to the intervention group or to the wait-list control group. Those who are randomized to the intervention group will receive the 4-week text intervention via smartphone and complete assessments (including urine drug screens) at baseline, 1 month, 3 months, and 6 months. Those who are randomized to the wait-list control group will only complete the assessments (including urine drug screens) at baseline, 1 month, 3 months, and 6 months. Participants who are initially assigned to the wait-list control group can choose to receive the text intervention once their 6-month participation is complete. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04567394
Study type Interventional
Source The University of Tennessee, Knoxville
Contact
Status Active, not recruiting
Phase N/A
Start date December 7, 2020
Completion date May 31, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04106336 - Cortical Excitability and Role of rTMS in Cannabis Use Disorder Early Phase 1
Recruiting NCT04964739 - Gender/Sex & CUD Remission N/A
Not yet recruiting NCT06225232 - Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study Phase 2
Completed NCT04923230 - Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse N/A
Completed NCT04902092 - Brain Exercise and Addiction Trial N/A
Recruiting NCT05064319 - Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders Phase 2